PubMed

Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study.

Ritz E, Viberti GC, Ruilope LM, Rabelink AJ, Izzo JL Jr, Katayama S, Ito S, Mimran A, Menne J, Rump LC, Januszewicz A, Haller H.

Diabetologia. 2009 Oct 30. [Epub ahead of print]PMID: 19876613 [PubMed - as supplied by publisher]Related articles

Effect of Rosiglitazone, Metformin, and Glyburide on Bone Biomarkers in Patients with Type 2 Diabetes.

Zinman B, Haffner SM, Herman WH, Holman RR, Lachin JM, Kravitz BG, Paul G, Jones NP, Aftring RP, Viberti G, Kahn SE; the A Diabetes Outcome Progression Trial Study Group.

J Clin Endocrinol Metab. 2009 Oct 29. [Epub ahead of print]PMID: 19875477 [PubMed - as supplied by publisher]Related articles

Antihypertensive effects of double the maximum dose of valsartan in African-American patients with type 2 diabetes mellitus and albuminuria.

Weir MR, Hollenberg NK, Zappe DH, Meng X, Parving HH, Viberti G, Remuzzi G.

J Hypertens. 2009 Oct 3. [Epub ahead of print]PMID: 19809363 [PubMed - as supplied by publisher]Related articles

Rosiglitazone Decreases C-Reactive Protein to a Greater Extent Relative to Glyburide and Metformin over Four-Years in Spite of Greater Weight Gain: Observations from ADOPT (A Diabetes Outcome Progression Trial).

Kahn SE, Haffner SM, Viberti G, Herman WH, Lachin JM, Kravitz BG, Yu D, Paul G, Holman RR, Zinman B; for the ADOPT Study Group.

Diabetes Care. 2009 Oct 16. [Epub ahead of print]PMID: 19808911 [PubMed - as supplied by publisher]Related articles

Mechanical forces and TGF{beta}1 reduce podocyte adhesion through {alpha}3{beta}1 integrin downregulation.

Dessapt C, Baradez MO, Hayward A, Dei Cas A, Thomas SM, Viberti G, Gnudi L.

Nephrol Dial Transplant. 2009 Sep;24(9):2645-55. Epub 2009 May 6.PMID: 19420102 [PubMed - in process]Related articles

Evaluation of rosiglitazone administration on cardiovascular function in severe obesity.

Brunani A, Liuzzi A, Titon A, Graci S, Castagna G, Viberti GC, Gondoni LA.

Clin Cardiol. 2008 Dec;31(12):602-6.PMID: 19097138 [PubMed - indexed for MEDLINE]Related articles

Genetic association analyses of non-synonymous single nucleotide polymorphisms in diabetic nephropathy.

Savage DA, Patterson CC, Deloukas P, Whittaker P, McKnight AJ, Morrison J, Boulton AJ, Demaine AG, Marshall SM, Millward BA, Thomas SM, Viberti GC, Walker JD, Sadlier D, Maxwell AP, Bain SC.

Diabetologia. 2008 Nov;51(11):1998-2002. Epub 2008 Sep 5.PMID: 18773191 [PubMed - indexed for MEDLINE]Related articlesFree article

Inducible overexpression of sFlt-1 in podocytes ameliorates glomerulopathy in diabetic mice.

Ku CH, White KE, Dei Cas A, Hayward A, Webster Z, Bilous R, Marshall S, Viberti G, Gnudi L.

Diabetes. 2008 Oct;57(10):2824-33. Epub 2008 Jul 22.PMID: 18647955 [PubMed - indexed for MEDLINE]Related articlesFree article

Valsartan improves arterial stiffness in type 2 diabetes independently of blood pressure lowering.

Karalliedde J, Smith A, DeAngelis L, Mirenda V, Kandra A, Botha J, Ferber P, Viberti G.

Hypertension. 2008 Jun;51(6):1617-23. Epub 2008 Apr 21.PMID: 18426991 [PubMed - indexed for MEDLINE]Related articlesFree article

Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT).

Kahn SE, Zinman B, Lachin JM, Haffner SM, Herman WH, Holman RR, Kravitz BG, Yu D, Heise MA, Aftring RP, Viberti G; Diabetes Outcome Progression Trial (ADOPT) Study Group.

Diabetes Care. 2008 May;31(5):845-51. Epub 2008 Jan 25.PMID: 18223031 [PubMed - indexed for MEDLINE]Related articlesFree article

Screening for chronic kidney disease in patients with diabetes: are we missing the point?

Thomas MC, Viberti G, Groop PH.

Nat Clin Pract Nephrol. 2008 Jan;4(1):2-3. Epub 2007 Nov 27. No abstract available. PMID: 18043592 [PubMed - indexed for MEDLINE]Related articles

Albuminuria response to very high-dose valsartan in type 2 diabetes mellitus.

Hollenberg NK, Parving HH, Viberti G, Remuzzi G, Ritter S, Zelenkofske S, Kandra A, Daley WL, Rocha R.

J Hypertens. 2007 Sep;25(9):1921-6.PMID: 17762658 [PubMed - indexed for MEDLINE]Related articles

Mechanical forces in diabetic kidney disease: a trigger for impaired glucose metabolism.

Gnudi L, Thomas SM, Viberti G.

J Am Soc Nephrol. 2007 Aug;18(8):2226-32. Epub 2007 Jul 18. Review.PMID: 17634438 [PubMed - indexed for MEDLINE]Related articlesFree article

Podocyte-specific expression of angiopoietin-2 causes proteinuria and apoptosis of glomerular endothelia.

Davis B, Dei Cas A, Long DA, White KE, Hayward A, Ku CH, Woolf AS, Bilous R, Viberti G, Gnudi L.

J Am Soc Nephrol. 2007 Aug;18(8):2320-9. Epub 2007 Jul 11.PMID: 17625119 [PubMed - indexed for MEDLINE]Related articlesFree article

HDL composition predicts new-onset cardiovascular disease in patients with type 1 diabetes.

Groop PH, Thomas MC, Rosengård-Bärlund M, Mills V, Rönnback M, Thomas S, Forsblom C, Taskinen MR, Viberti G.

Diabetes Care. 2007 Oct;30(10):2706-7. Epub 2007 Jul 9. No abstract available. PMID: 17620444 [PubMed - indexed for MEDLINE]Related articlesFree article

Hyperhomocysteinemia in winter elite athletes: a longitudinal study.

Borrione P, Pigozzi F, Massazza G, Schonhuber H, Viberti G, Paccotti P, Angeli A.

J Endocrinol Invest. 2007 May;30(5):367-75.PMID: 17598967 [PubMed - indexed for MEDLINE]Related articles

Misleading meta-analysis: a need to look beyond the headlines.

Chaturvedi N, Bilous R, Hardy R, Remuzzi G, Ruggenenti P, Viberti GC.

Diabet Med. 2007 Jun;24(6):587-91. Epub 2007 May 8. No abstract available. PMID: 17490423 [PubMed - indexed for MEDLINE]Related articles

Comment on: Boden et al. (2007) Combined use of rosiglitazone and fenofibrate in patients with type 2 diabetes: prevention of fluid retention: Diabetes 56:248-255.

Karalliedde J, Viberti GC.

Diabetes. 2007 May;56(5):e3; author reply e4. No abstract available. PMID: 17470560 [PubMed - indexed for MEDLINE]Related articlesFree article

Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients.

Brunani A, Caumo A, Graci S, Castagna G, Viberti G, Liuzzi A.

Diabetes Obes Metab. 2008 Jun;10(6):460-7. Epub 2007 Mar 29.PMID: 17394563 [PubMed - indexed for MEDLINE]Related articles

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.

Kahn SE, Haffner SM, Heise MA, Herman WH, Holman RR, Jones NP, Kravitz BG, Lachin JM, O'Neill MC, Zinman B, Viberti G; ADOPT Study Group.

N Engl J Med. 2006 Dec 7;355(23):2427-43. Epub 2006 Dec 4. Erratum in: N Engl J Med. 2007 Mar 29;356(13):1387-8. PMID: 17145742 [PubMed - indexed for MEDLINE]Related articlesFree article

A Diabetes Outcome Progression Trial (ADOPT): baseline characteristics of Type 2 diabetic patients in North America and Europe.

Viberti G, Lachin J, Holman R, Zinman B, Haffner S, Kravitz B, Heise MA, Jones NP, O'Neill MC, Freed MI, Kahn SE, Herman WH; for the ADOPT Study Group.

Diabet Med. 2006 Dec;23(12):1289-94.PMID: 17116177 [PubMed - indexed for MEDLINE]Related articles

The link between mechanical stretch and glucose metabolism--a conceptual advance in understanding diabetic (and non diabetic?) renal disease.

Gnudi L, Viberti G.

Nephrol Dial Transplant. 2007 Feb;22(2):318-21. Epub 2006 Nov 18. No abstract available. PMID: 17114798 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of various diuretic treatments on rosiglitazone-induced fluid retention.

Karalliedde J, Buckingham R, Starkie M, Lorand D, Stewart M, Viberti G; Rosiglitazone Fluid Retention Study Group.

J Am Soc Nephrol. 2006 Dec;17(12):3482-90. Epub 2006 Nov 8.PMID: 17093067 [PubMed - indexed for MEDLINE]Related articlesFree article

No change in glomerular heparan sulfate structure in early human and experimental diabetic nephropathy.

van den Born J, Pisa B, Bakker MA, Celie JW, Straatman C, Thomas S, Viberti GC, Kjellen L, Berden JH.

J Biol Chem. 2006 Oct 6;281(40):29606-13. Epub 2006 Aug 1.PMID: 16885165 [PubMed - indexed for MEDLINE]Related articlesFree article

Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes.

Kahn SE, Zinman B, Haffner SM, O'Neill MC, Kravitz BG, Yu D, Freed MI, Herman WH, Holman RR, Jones NP, Lachin JM, Viberti GC; ADOPT Study Group.

Diabetes. 2006 Aug;55(8):2357-64.PMID: 16873701 [PubMed - indexed for MEDLINE]Related articlesFree article

Period prevalence of abnormal glucose tolerance and cardiovascular risk factors among obese children attending an obesity centre in Italy.

Invitti C, Gilardini L, Pontiggia B, Morabito F, Mazzilli G, Viberti G.

Nutr Metab Cardiovasc Dis. 2006 May;16(4):256-62. Epub 2006 Jan 4.PMID: 16679217 [PubMed - indexed for MEDLINE]Related articles

Metabolic syndrome in obese Caucasian children: prevalence using WHO-derived criteria and association with nontraditional cardiovascular risk factors.

Invitti C, Maffeis C, Gilardini L, Pontiggia B, Mazzilli G, Girola A, Sartorio A, Morabito F, Viberti GC.

Int J Obes (Lond). 2006 Apr;30(4):627-33.PMID: 16570092 [PubMed - indexed for MEDLINE]Related articles

The MCP-1/CCR2 system has direct proinflammatory effects in human mesangial cells.

Giunti S, Pinach S, Arnaldi L, Viberti G, Perin PC, Camussi G, Gruden G.

Kidney Int. 2006 Mar;69(5):856-63.PMID: 16518346 [PubMed - indexed for MEDLINE]Related articles

Preventing microalbuminuria in patients with diabetes: rationale and design of the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study.

Haller H, Viberti GC, Mimran A, Remuzzi G, Rabelink AJ, Ritz E, Rump LC, Ruilope LM, Katayama S, Ito S, Izzo JL Jr, Januszewicz A.

J Hypertens. 2006 Feb;24(2):403-8.PMID: 16508590 [PubMed - indexed for MEDLINE]Related articles

Evidence for renoprotection by blockade of the renin-angiotensin-aldosterone system in hypertension and diabetes.

Karalliedde J, Viberti G.

J Hum Hypertens. 2006 Apr;20(4):239-53. Review.PMID: 16452996 [PubMed - indexed for MEDLINE]Related articles

Serum lipids and the progression of nephropathy in type 1 diabetes.

Thomas MC, Rosengård-Bärlund M, Mills V, Rönnback M, Thomas S, Forsblom C, Cooper ME, Taskinen MR, Viberti G, Groop PH.

Diabetes Care. 2006 Feb;29(2):317-22.PMID: 16443880 [PubMed - indexed for MEDLINE]Related articlesFree article

Direct regulation of insulin secretion by angiotensin II in human islets of Langerhans.

Ramracheya RD, Muller DS, Wu Y, Whitehouse BJ, Huang GC, Amiel SA, Karalliedde J, Viberti G, Jones PM, Persaud SJ.

Diabetologia. 2006 Feb;49(2):321-31. Epub 2006 Jan 17.PMID: 16416272 [PubMed - indexed for MEDLINE]Related articles

Determinants of response to insulin therapy following failure of oral agents in type 2 diabetes.

Karalliedde J, Smith A, Viberti G.

Diabetes Care. 2005 Oct;28(10):2589-90. No abstract available. PMID: 16186308 [PubMed - indexed for MEDLINE]Related articlesFree article

Cardiovascular risk in diabetic kidney disease: a model of chronic renal disease.

Thomas SM, Viberti GC.

Kidney Int Suppl. 2005 Sep;(98):S18-20. No abstract available. PMID: 16108965 [PubMed - indexed for MEDLINE]Related articles

Prevention of chronic kidney and vascular disease: toward global health equity--the Bellagio 2004 Declaration.

Dirks JH, de Zeeuw D, Agarwal SK, Atkins RC, Correa-Rotter R, D'Amico G, Bennett PH, El Nahas M, Valdes RH, Kaseje D, Katz IJ, Naicker S, Rodriguez-Iturbe B, Schieppati A, Shaheen F, Sitthi-Amorn C, Solez K, Viberti G, Remuzzi G, Weening JJ; International Society of Nephrology Commission for the Global Advancement of Nephrology Study Group 2004.

Kidney Int Suppl. 2005 Sep;(98):S1-6.PMID: 16108963 [PubMed - indexed for MEDLINE]Related articles

Targeting albumin excretion rate in the treatment of the hypertensive diabetic patient with renal disease.

Krimholtz MJ, Karalliedde J, Thomas S, Bilous R, Viberti G.

J Am Soc Nephrol. 2005 Mar;16 Suppl 1:S42-7.PMID: 15938033 [PubMed - indexed for MEDLINE]Related articlesFree article

Thiazolidinediones-benefits on microvascular complications of type 2 diabetes.

Viberti G.

J Diabetes Complications. 2005 May-Jun;19(3):168-77. Review.PMID: 15866064 [PubMed - indexed for MEDLINE]Related articles

Aortic pulse wave velocity and albuminuria in patients with type 2 diabetes.

Smith A, Karalliedde J, De Angelis L, Goldsmith D, Viberti G.

J Am Soc Nephrol. 2005 Apr;16(4):1069-75. Epub 2005 Mar 2.PMID: 15743996 [PubMed - indexed for MEDLINE]Related articlesFree article

Hypertension and microalbuminuria: risk factors for cardiovascular disease in diabetes.

Karalliedde J, Viberti G.

Curr Hypertens Rep. 2005 Feb;7(1):1-2. No abstract available. PMID: 15683578 [PubMed - indexed for MEDLINE]Related articles

Mechanical stretch induces monocyte chemoattractant activity via an NF-kappaB-dependent monocyte chemoattractant protein-1-mediated pathway in human mesangial cells: inhibition by rosiglitazone.

Gruden G, Setti G, Hayward A, Sugden D, Duggan S, Burt D, Buckingham RE, Gnudi L, Viberti G.

J Am Soc Nephrol. 2005 Mar;16(3):688-96. Epub 2005 Jan 26.PMID: 15677312 [PubMed - indexed for MEDLINE]Related articlesFree article

Revised vs original QUICKI index during diet + rosiglitazone treatment in obese subjects.

Brunani A, Caumo A, Graci S, Margarini C, Viberti GC, Liuzzi A.

Diabetes Metab. 2004 Nov;30(5):409-10. No abstract available. PMID: 15671907 [PubMed - indexed for MEDLINE]Related articlesFree article

-to: Ong KK, Petry CJ, Emmett PM et al.; ALSPAC study team (2004) Insulin sensitivity and secretion in normal children related to size at birth, postnatal growth, and plasma insulin-like growth factor-I levels. Diabetologia 47:1064-1070.

Invitti C, Gilardini L, Mazzilli G, Sartorio A, Viberti GC.

Diabetologia. 2004 Nov;47(11):2044-5; author reply 2046. Epub 2004 Nov 24. No abstract available. PMID: 15565365 [PubMed - indexed for MEDLINE]Related articles

Microalbuminuria and cardiovascular risk.

Karalliedde J, Viberti G.

Am J Hypertens. 2004 Oct;17(10):986-93. Review.PMID: 15485765 [PubMed - indexed for MEDLINE]Related articles

Obesity and the metabolic syndrome in children and adolescents.

Invitti C, Gilardini L, Viberti G.

N Engl J Med. 2004 Sep 9;351(11):1146-8; author reply 1146-8. No abstract available. PMID: 15359432 [PubMed - indexed for MEDLINE]Related articles

Lack of evidence for the 1484insG variant at the 3'-UTR of the protein tyrosine phosphatase 1B (PTP1B) gene as a genetic determinant of diabetic nephropathy development in type 1 diabetic patients.

De Cosmo S, Marucci A, Ciociola E, Di Paola R, Pucci L, Penno G, Del Prato S, Piras GP, Trevisan R, Giunti S, Viberti GC, Trischitta V.

Nephrol Dial Transplant. 2004 Sep;19(9):2419-20. No abstract available. PMID: 15299110 [PubMed - indexed for MEDLINE]Related articlesFree article

Accurate measurement of albuminuria at reduced cost.

Krimholtz M, Smith A, Viberti G.

Nephrol Dial Transplant. 2004 Jul;19(7):1934-5. No abstract available. PMID: 15199207 [PubMed - indexed for MEDLINE]Related articlesFree article

Sex differences in age-related stiffening of the aorta in subjects with type 2 diabetes.

De Angelis L, Millasseau SC, Smith A, Viberti G, Jones RH, Ritter JM, Chowienczyk PJ.

Hypertension. 2004 Jul;44(1):67-71. Epub 2004 May 17.PMID: 15148292 [PubMed - indexed for MEDLINE]Related articlesFree article

Regression of albuminuria: latest evidence for a new approach.

Viberti G.

J Hypertens Suppl. 2003 Jun;21(3):S24-8. Review.PMID: 12929472 [PubMed - indexed for MEDLINE]Related articles

GLUT-1 overexpression: Link between hemodynamic and metabolic factors in glomerular injury?

Gnudi L, Viberti G, Raij L, Rodriguez V, Burt D, Cortes P, Hartley B, Thomas S, Maestrini S, Gruden G.

Hypertension. 2003 Jul;42(1):19-24. Epub 2003 May 27.PMID: 12771048 [PubMed - indexed for MEDLINE]Related articlesFree article

The need for tighter control of cardiovascular risk factors in diabetic patients.

Viberti G.

J Hypertens Suppl. 2003 Mar;21(1):S3-6. Review.PMID: 12769160 [PubMed - indexed for MEDLINE]Related articles